https://www.hcplive.com/view/injection-intervals-extended-namd-eyes-switch-brolucizumab
Injection Intervals Extended in nAMD Eyes with Switch to Brolucizumab | HCPLive
Oct 10, 2026 - Real-world data suggest nAMD eyes can extend injection intervals by switching to brolucizumab from other anti-VEGF therapies, while maintaining vision and...
injectionintervalsextendednamdeyes
https://sciforum.net/paper/7435
Evaluation of the efficacy in visual function improvement of brolucizumab with aflibercept in...
Age-related macular degeneration (AMD) is the leading cause of blindness among the elderly in the developed world
of theevaluationefficacyvisualfunction
https://hkjo.hk/index.php/hkjo/article/view/327?articlesBySameAuthorPage=2
Brolucizumab and faricimab as new treatment options for diabetic macular edema: perspective | Hong...
diabetic macular edematreatment optionsbrolucizumabfaricimabnew
https://www.akdae.de/arzneimitteltherapie/arzneiverordnung-in-der-praxis/ausgaben-archiv/ausgaben-ab-2015/ausgabe/artikel/2022/2022-3/brolucizumab-beovur-indikationserweiterung-1
Brolucizumab (Beovu®) ▼ – Indikationserweiterung - Arzneimittelkommission der deutschen Ärzteschaft
brolucizumabderdeutschen